Effects of selective heart rate reduction with ivabradine on left ventricular remodelling and function: results from the SHIFT echocardiography substudy (Q34631911)

From Wikidata

Jump to navigation Jump to search

scientific article published on August 29, 2011

Language	Label	Description	Also known as
English	Effects of selective heart rate reduction with ivabradine on left ventricular remodelling and function: results from the SHIFT echocardiography substudy	scientific article published on August 29, 2011

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Effects of selective heart rate reduction with ivabradine on left ventricular remodelling and function: results from the SHIFT echocardiography substudy (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

echocardiography

1 reference

based on heuristic

inferred from title

7

object named as

Luigi Tavazzi

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

3

object named as

Michel Komajda

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

8

object named as

Karl Swedberg

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Jean-Claude Tardif

1

object named as

Jean-Claude Tardif

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

author name string

Eileen O'Meara

2

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Michael Böhm

4

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Ian Ford

6

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

SHIFT Investigators

9

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Jeffrey S. Borer

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21875858

11 December 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21875858

11 December 2024

publication date

29 August 2011

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

full work available at URL

https://academic.oup.com/eurheartj/article-pdf/32/20/2507/17049425/ehr311.pdf

Portable Document Format

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21875858

11 December 2024

https://europepmc.org/articles/PMC3195263

HyperText Markup Language

online access status

content deliverer

Europe PubMed Central

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21875858

11 December 2024

http://academic.oup.com/eurheartj/article-pdf/32/20/2507/17049425/ehr311.pdf

Portable Document Format

1 reference

10.1093/EURHEARTJ/EHR311

https://api.crossref.org/works/10.1093/EURHEARTJ/EHR311

11 December 2024

European Heart Journal

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

32

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

20

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

2507-2515

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Titration to target dose of bisoprolol vs. carvedilol in elderly patients with heart failure: the CIBIS-ELD trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3195263

7 July 2018

Effect of Left Ventricular Reverse Remodeling on Long-Term Prognosis After Therapy With Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers and β Blockers in Patients With Idiopathic Dilated Cardiomyopathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3195263

7 July 2018

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3195263

7 July 2018

Quantitative evaluation of drug or device effects on ventricular remodeling as predictors of therapeutic effects on mortality in patients with heart failure and reduced ejection fraction: a meta-analytic approach

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3195263

7 July 2018

Cardiac resynchronization induces major structural and functional reverse remodeling in patients with New York Heart Association class I/II heart failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3195263

7 July 2018

Beneficial effects of delayed ivabradine treatment on cardiac anatomical and electrical remodeling in rat severe chronic heart failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3195263

7 July 2018

Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3195263

7 July 2018

Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3195263

7 July 2018

Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR311

21 January 2018

Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR311

21 January 2018

Rationale and design of a randomized, double-blind, placebo-controlled outcome trial of ivabradine in chronic heart failure: the Systolic Heart Failure Treatment with the I(f) Inhibitor Ivabradine Trial (SHIFT).

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR311

21 January 2018

Effect of heart rate reduction by ivabradine on left ventricular remodeling in the echocardiographic substudy of BEAUTIFUL

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR311

21 January 2018

Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR311

21 January 2018

Effects of carvedilol on left ventricular remodeling after acute myocardial infarction: the CAPRICORN Echo Substudy

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR311

21 January 2018

Prognostic value of bisoprolol-induced hemodynamic effects in heart failure during the Cardiac Insufficiency BIsoprolol Study (CIBIS).

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR311

21 January 2018

The effect of treatment with bisoprolol-first versus enalapril-first on cardiac structure and function in heart failure.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHR311

21 January 2018

Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardio

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3195263

26 October 2018

Heart rate reduction with ivabradine prevents the global phenotype of left ventricular remodeling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3195263

9 December 2018

Effects of angiotensin-converting enzyme inhibition with perindopril on left ventricular remodeling and clinical outcome: results of the randomized Perindopril and Remodeling in Elderly with Acute Myocardial Infarction (PREAMI) Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/21875858

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preservation of coronary reserve by ivabradine-induced reduction in heart rate in infarcted rats is associated with decrease in perivascular collagen

1 reference

https://pubmed.ncbi.nlm.nih.gov/21875858

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1093/EURHEARTJ/EHR311

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34631911&oldid=2285892138"